Lista de obras - Renumathy Dhanasekaran - Dominio Público Uruguay

A Tale of Two Complications of Obesity: NASH and Hepatocellular Carcinoma

scientific article published on 27 May 2019

Activation of the transforming growth factor-β/SMAD transcriptional pathway underlies a novel tumor-promoting role of sulfatase 1 in hepatocellular carcinoma

artículo científico publicado en 2015

Anti-miR-17 therapy delays tumorigenesis in MYC-driven hepatocellular carcinoma (HCC).

artículo científico publicado en 2017

Bridging Locoregional Therapy Prolongs Survival in Patients Listed for Liver Transplant with Hepatocellular Carcinoma.

artículo científico publicado en 2016

Challenges of recurrent hepatitis C in the liver transplant patient

artículo científico publicado en 2014

Clinical implications of basic research in hepatocellular carcinoma

artículo científico publicado en 2015

Comparison of conventional transarterial chemoembolization (TACE) and chemoembolization with doxorubicin drug eluting beads (DEB) for unresectable hepatocelluar carcinoma (HCC)

artículo científico publicado en 2010

Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients

artículo científico

Comprehensive Characterization of Cancer Driver Genes and Mutations

article

Direct-Acting Antiviral Therapy Not Associated With Recurrence of Hepatocellular Carcinoma in a Multicenter North American Cohort Study

artículo científico publicado en 2019

Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection Is Associated With Increased Survival in Patients With a History of Hepatocellular Carcinoma

artículo científico publicado en 2019

Effects of immunosuppressive drugs on COVID‐19 severity in patients with autoimmune hepatitis

artículo científico publicado en 2021

Erratum to “Clinical implications of basic research in hepatocellular carcinoma” [J Hepatol 2016;64:736–745]

artículo científico publicado en 2016

Genomic Medicine and Implications for Hepatocellular Carcinoma Prevention and Therapy

artículo científico publicado en 2018

Genomic analysis of Vascular Invasion in Hepatocellular Carcinoma (HCC) Reveals Molecular Drivers and Predictive Biomarkers

artículo científico publicado en 2020

Hepatic preservation injury: severity of hepatitis C recurrence and survival after liver transplantation.

artículo científico publicado en 2013

Impact of Bridging Locoregional Therapies for Hepatocellular Carcinoma on Post-Transplant Clinical Outcome

artículo científico publicado en 2020

Impact of fibrosis progression on clinical outcome in patients treated for post-transplant hepatitis C recurrence.

artículo científico publicado en 2015

Impact of transarterial therapy in hepatitis C-related hepatocellular carcinoma on long-term outcomes after liver transplantation

artículo científico publicado en 2012

Lipid nanoparticles that deliver IL-12 messenger RNA suppress tumorigenesis in MYC oncogene-driven hepatocellular carcinoma

artículo científico publicado en 2018

Liver Injury in Liver Transplant Recipients with Coronavirus Disease 2019 (COVID-19): US Multicenter Experience

artículo científico publicado en 2020

Liver test results do not identify liver disease in adults with α(1)-antitrypsin deficiency

artículo científico publicado en 2012

Management of Immunosuppression in Liver Transplantation.

artículo científico publicado en 2017

Molecular pathogenesis of hepatocellular carcinoma and impact of therapeutic advances

artículo científico publicado en 2016

One world, one pandemic, many guidelines: management of liver diseases during COVID-19

scientific article published on 04 June 2020

Post-Transplant Outcomes in Older Patients with Hepatocellular Carcinoma (HCC) are Driven by non-HCC Factors

scientific article published on 11 December 2020

Predictors of Outcomes of Patients Referred to a Transplant Center for Urgent Liver Transplantation Evaluation

artículo científico publicado en 2020

Prognostic factors for survival in patients with unresectable hepatocellular carcinoma undergoing chemoembolization with doxorubicin drug-eluting beads: a preliminary study.

artículo científico publicado en 2010

Quality of Cancer Care in Patients with Cirrhosis and Hepatocellular Carcinoma

artículo científico

Rare case of adult undifferentiated (embryonal) sarcoma of the liver treated with liver transplantation: excellent long-term survival.

artículo científico publicado en 2012

Response to Fibrosis progression in patients treated for hepatitis C recurrence.

artículo científico publicado en 2015

Response to Houlihan et al.

artículo científico publicado en 2013

Ribosomal protein S15a promotes tumor angiogenesis via enhancing Wnt/β-catenin-induced FGF18 expression in hepatocellular carcinoma.

artículo científico publicado en 2017

Safety and efficacy of doxorubicin drug-eluting bead transarterial chemoembolization in patients with advanced hepatocellular carcinoma.

artículo científico publicado en 2013

Selective Internal Yttrium-90 Radioembolization Therapy (90Y-SIRT) Versus Best Supportive Care in Patients With Unresectable Metastatic Melanoma to the Liver Refractory to Systemic Therapy: Safety and Efficacy Cohort Study.

artículo científico

Socioeconomic Factors Contribute to the Higher Risk of COVID-19 in Racial and Ethnic Minorities with Chronic Liver Diseases (CLD)

artículo científico publicado en 2020

Spontaneous Regression of HCC- When the Immune System Stands Up to Cancer

artículo científico publicado en 2020

The effectiveness of locoregional therapies versus supportive care in maintaining survival within the Milan criteria in patients with hepatocellular carcinoma

artículo científico publicado en 2010

Transcriptional Induction of Periostin by a Sulfatase 2-TGFβ1-SMAD Signaling Axis Mediates Tumor Angiogenesis in Hepatocellular Carcinoma.

artículo científico publicado en 2016

Tumoral and angiogenesis factors in hepatocellular carcinoma after locoregional therapy

artículo científico publicado en 2011

Vasodilator-stimulated phosphoprotein promotes activation of hepatic stellate cells by regulating Rab11-dependent plasma membrane targeting of transforming growth factor beta receptors

artículo científico publicado en 2014

YAP-associated chromosomal instability and cholangiocarcinoma in mice.

artículo científico publicado en 2017

and cooperate to drive metastasis by eliciting crosstalk between cancer and innate immunity

scientific article published on 14 January 2020

Lista de obras de Renumathy Dhanasekaran

A Tale of Two Complications of Obesity: NASH and Hepatocellular Carcinoma

Activation of the transforming growth factor-β/SMAD transcriptional pathway underlies a novel tumor-promoting role of sulfatase 1 in hepatocellular carcinoma

Anti-miR-17 therapy delays tumorigenesis in MYC-driven hepatocellular carcinoma (HCC).

Bridging Locoregional Therapy Prolongs Survival in Patients Listed for Liver Transplant with Hepatocellular Carcinoma.

Challenges of recurrent hepatitis C in the liver transplant patient

Clinical implications of basic research in hepatocellular carcinoma

Comparison of conventional transarterial chemoembolization (TACE) and chemoembolization with doxorubicin drug eluting beads (DEB) for unresectable hepatocelluar carcinoma (HCC)

Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients

Comprehensive Characterization of Cancer Driver Genes and Mutations

Direct-Acting Antiviral Therapy Not Associated With Recurrence of Hepatocellular Carcinoma in a Multicenter North American Cohort Study

Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection Is Associated With Increased Survival in Patients With a History of Hepatocellular Carcinoma

Effects of immunosuppressive drugs on COVID‐19 severity in patients with autoimmune hepatitis

Erratum to “Clinical implications of basic research in hepatocellular carcinoma” [J Hepatol 2016;64:736–745]

Genomic Medicine and Implications for Hepatocellular Carcinoma Prevention and Therapy

Genomic analysis of Vascular Invasion in Hepatocellular Carcinoma (HCC) Reveals Molecular Drivers and Predictive Biomarkers

Hepatic preservation injury: severity of hepatitis C recurrence and survival after liver transplantation.

Impact of Bridging Locoregional Therapies for Hepatocellular Carcinoma on Post-Transplant Clinical Outcome

Impact of fibrosis progression on clinical outcome in patients treated for post-transplant hepatitis C recurrence.

Impact of transarterial therapy in hepatitis C-related hepatocellular carcinoma on long-term outcomes after liver transplantation

Lipid nanoparticles that deliver IL-12 messenger RNA suppress tumorigenesis in MYC oncogene-driven hepatocellular carcinoma

Liver Injury in Liver Transplant Recipients with Coronavirus Disease 2019 (COVID-19): US Multicenter Experience

Liver test results do not identify liver disease in adults with α(1)-antitrypsin deficiency

Management of Immunosuppression in Liver Transplantation.

Molecular pathogenesis of hepatocellular carcinoma and impact of therapeutic advances

One world, one pandemic, many guidelines: management of liver diseases during COVID-19

Post-Transplant Outcomes in Older Patients with Hepatocellular Carcinoma (HCC) are Driven by non-HCC Factors

Predictors of Outcomes of Patients Referred to a Transplant Center for Urgent Liver Transplantation Evaluation

Prognostic factors for survival in patients with unresectable hepatocellular carcinoma undergoing chemoembolization with doxorubicin drug-eluting beads: a preliminary study.

Quality of Cancer Care in Patients with Cirrhosis and Hepatocellular Carcinoma

Rare case of adult undifferentiated (embryonal) sarcoma of the liver treated with liver transplantation: excellent long-term survival.

Response to Fibrosis progression in patients treated for hepatitis C recurrence.

Response to Houlihan et al.

Ribosomal protein S15a promotes tumor angiogenesis via enhancing Wnt/β-catenin-induced FGF18 expression in hepatocellular carcinoma.

Safety and efficacy of doxorubicin drug-eluting bead transarterial chemoembolization in patients with advanced hepatocellular carcinoma.

Selective Internal Yttrium-90 Radioembolization Therapy (90Y-SIRT) Versus Best Supportive Care in Patients With Unresectable Metastatic Melanoma to the Liver Refractory to Systemic Therapy: Safety and Efficacy Cohort Study.

Socioeconomic Factors Contribute to the Higher Risk of COVID-19 in Racial and Ethnic Minorities with Chronic Liver Diseases (CLD)

Spontaneous Regression of HCC- When the Immune System Stands Up to Cancer

The effectiveness of locoregional therapies versus supportive care in maintaining survival within the Milan criteria in patients with hepatocellular carcinoma

Transcriptional Induction of Periostin by a Sulfatase 2-TGFβ1-SMAD Signaling Axis Mediates Tumor Angiogenesis in Hepatocellular Carcinoma.

Tumoral and angiogenesis factors in hepatocellular carcinoma after locoregional therapy

Vasodilator-stimulated phosphoprotein promotes activation of hepatic stellate cells by regulating Rab11-dependent plasma membrane targeting of transforming growth factor beta receptors

YAP-associated chromosomal instability and cholangiocarcinoma in mice.

and cooperate to drive metastasis by eliciting crosstalk between cancer and innate immunity